Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Biscuiteers sell collections of hand iced biscuits for every occasion. Their aim is to offer a more unique, stylish and personalised gifting solution. Biscuiteers currently have two retail stores, one is located in Notting Hill and the other in Northcote Road.
days to go:
Expired
investment:
£1,245,660
NGX is the world’s first genetically personalised nutrition shake designed to bring nutrition to everyday athletes. The company has ongoing discussions to form partners with U.A.E and U.S to expand. NGX's nutritionist approved formula is a less than average vegan-friendly, environmentally responsible, allergen-free, naturally sourced, and macro trends within the millennial and Z generations. With the proceeds, the company aims to create a range of products from personalised meal plans, and protein bars to enhance its position as the go-to personalised nutrition brand.
days to go:
Expired
investment:
£207,860
Itailians clubhouse is a new type of clubhouse located in London. The members can enjoy casual and fine dining, cocktails and fine wines. They can also just use the private lounges, rooms, offices and terrace. Itailians clubhouse mostly focus on fashion, design, art and hospitiality. The funding will be used to refurbish their existing building and to also look for new venues all around london.
days to go:
Expired
investment:
£584,661
Mr. Singh’s is a family-run business from East London, dedicated to making all-natural, 100% vegan Chilli sauces (ranked No. 1 in the UK by the Metro newspaper), award-winning cooking paste and Chili crisps. The company is gaining nationwide fame with demands for new flavours flowing in from its growing client base that includes independent pubs and retailers like WHSmith’s and Ocado. Mr. Singh’s newest and potential clients include a UK-based Vegan subscription box company and a company who owns 300+ petrol station shops around the UK. Owing to this success, Mr. Singh’s is looking at export channels to increase their presence beyond the UK.
days to go:
Expired
investment:
£52,437
The world's first alcoholic drinks company adding collagen to spirits with an elegant and refined taste. This unique recipe has stayed true to the principles of a classic gin but with a rejuvenating twist of anti-ageing botanicals such as pink grapefruit, star anise and fresh orange, with the innovative addition of pure collagen. The collagen market is estimated to be worth $6.63bn by 2025. Till now, 27,000 bottles sold, secured over 200 UK stockists including Ocado & Amazon, successful tastings at Taste London, BBC Good Food and appeared in over 300 media outlets including Lorraine, Sky News, Vogue, Daily Telegraph and Sunday Times. With the proceeds, they will launch internationally, maximise untapped UK opportunities and aim to become the leader in the new and evolving collagen markets.
days to go:
Expired
investment:
£26,700
Priding themselves with their Aussie-Japanese sushi handrolls, Inigo have introduced the delicacy to London and are now ready to expand. The company has partnered with a leading smokehouse, H. Forman & Son's who provide the kitchen, produce and expertise. Inigo currently have operate from a kiosk in the city centre, with more planned. They offer B2B services and supply corporate businesses including Visa HQ, Amazon HQ and UBS.
days to go:
Expired
investment:
£179,840
